Previous Close | 0.0003 |
Open | 0.0004 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.0002 - 0.0004 |
52 Week Range | 0.0002 - 0.1400 |
Volume | |
Avg. Volume | 16,669,481 |
Market Cap | 25,591 |
Beta (5Y Monthly) | 0.79 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3300 |
Earnings Date | Mar 28, 2024 - Mar 30, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for INLB
Item 9 Labs Corp. (OTCPK: INLB) ("INLB" or the "Company"), a vertically integrated cannabis operator and dispensary franchisor that produces high-grade, award-winning products has retained Sharp Capital Advisors LLC ("Sharp") to assist in the exploration of a sale of the Company. The Company consists of two core operating businesses, Item 9 Labs and Unity Rd.
PHOENIX, May 23, 2023--INLB Corp. has executed a major restructuring to right-size its operations and cost structure while working toward a return to profitability.
PHOENIX, May 10, 2023--After a successful test run in December, Item 9 Labs released its limited edition one-gram rosin-infused pre-rolls in participating AZ dispensaries.